| 000 | 01832 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250518034556.0 | ||
| 264 | 0 | _c20190813 | |
| 008 | 201908s 0 0 eng d | ||
| 022 | _a1422-0067 | ||
| 024 | 7 |
_a10.3390/ijms20081821 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMotoi, Sotaro | |
| 245 | 0 | 0 |
_aAnti-Apoptotic Effects of Recombinant Human Hepatocyte Growth Factor on Hepatocytes Were Associated with Intrahepatic Hemorrhage Suppression Indicated by the Preservation of Prothrombin Time. _h[electronic resource] |
| 260 |
_bInternational journal of molecular sciences _cApr 2019 |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBlood Coagulation _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aHemorrhage _xdrug therapy |
| 650 | 0 | 4 |
_aHepatocyte Growth Factor _xpharmacology |
| 650 | 0 | 4 |
_aHepatocytes _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 |
_aLiver Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aLiver Failure, Acute _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aProthrombin Time |
| 650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
| 650 | 0 | 4 |
_afas Receptor _xmetabolism |
| 700 | 1 | _aToyoda, Hiroko | |
| 700 | 1 | _aObara, Takashi | |
| 700 | 1 | _aOhta, Etsuko | |
| 700 | 1 | _aArita, Yoshihisa | |
| 700 | 1 | _aNegishi, Kana | |
| 700 | 1 | _aMoriya, Katsuhiro | |
| 700 | 1 | _aKuboi, Yoshikazu | |
| 700 | 1 | _aSoejima, Motohiro | |
| 700 | 1 | _aImai, Toshio | |
| 700 | 1 | _aIdo, Akio | |
| 700 | 1 | _aTsubouchi, Hirohito | |
| 700 | 1 | _aKawano, Tetsu | |
| 773 | 0 |
_tInternational journal of molecular sciences _gvol. 20 _gno. 8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3390/ijms20081821 _zAvailable from publisher's website |
| 999 |
_c29616751 _d29616751 |
||